NYSEARCA:XBISPDR S&P Biotech ETF Stock Price, Forecast & News

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, XBI shares have increased by 42.9% and is now trading at $112.89. View which stocks have been most impacted by Coronavirus.

SPDR S&P Biotech ETF declared a quarterly dividend on Friday, December 20th. Investors of record on Monday, December 23rd will be given a dividend of $0.0009 per share on Thursday, December 26th. This represents a $0.00 annualized dividend and a dividend yield of 0.00%. The ex-dividend date of this dividend is Friday, December 20th. View SPDR S&P Biotech ETF's dividend history.

Media headlines about XBI stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. SPDR S&P Biotech ETF earned a news impact score of -1.3 on InfoTrie's scale. They also assigned news coverage about the exchange traded fund a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about SPDR S&P Biotech ETF.

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include iShares Nasdaq Biotechnology ETF (IBB), NVIDIA (NVDA), Netflix (NFLX), Walt Disney (DIS), Intel (INTC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Cisco Systems (CSCO) and Pfizer (PFE).

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

SPDR S&P Biotech ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include M&R Capital Management Inc. (0.04%).

XBI stock was acquired by a variety of institutional investors in the last quarter, including M&R Capital Management Inc..

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of XBI stock can currently be purchased for approximately $112.89.

SPDR S&P Biotech ETF has a market capitalization of $5.44 billion.

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.